Fagron Compounding Services recalls Lidocaine HCl Injection
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Lack of Assurance of Sterility
- Products
-
- Lidocaine HCl Injection
- Company
- Fagron Compounding Services
- Where it was sold
-
Nationwide in the USA
Nationwide
- About this recall
- Lidocaine HCl Injection, 2% (20mg per mL) (100 mg per 5 mL) per syringe, Rx only, Fagron Sterile Services, 8710 E. 34th St, N. Wichita, KS 57226.